COX inhibitor Fenbufen, Purity ≥98%

Cat. No.: X23-10-ZQ632

COX inhibitor Fenbufen, Purity ≥98%

Synonym: Fenbufen; 36330-85-5; Lederfen; Cinopal; Bufemid; Napanol; 4-(4-Biphenylyl)-4-oxobutyric acid; COX inhibitor

  • MDL: MFCD00056701
  • CAS Number: 36330-85-5
  • Compound CID: 3335
Product Size
100 mg; 250 mg; 500 mg; 1000 mg
Price
Datasheet
MSDS
Properties
Description
Fenbufen, soluble in DMSO and ethanol and insoluble in water, blocks the COX enzymes from converting arachidonic acid to prostaglandins, thereby reducing inflammatory reactions. It targets cyclooxygenase and ATP systhesis.
Molecular Weight
254.28
Molecular Formula
C16H14O3
Targets
cyclooxygenase; ATP systhesis: 0.88 μM (Ki)
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 45 mg/mL (176.97 mM); Water: Insoluble; Ethanol: 45 mg/mL (176.97 mM)
Identity
Confirmed by NMR/HPLC/MS.
Applications
Fenbufen is used in studies focusing on its anti-inflammatory and pain relief properties, often in the context of arthritis and other inflammatory conditions.
Related Products

Thanksgiving 2024

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0